The fight against multidrug-resistant organisms: The role of ZnO crystalline defects
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 99, 575-581
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Economy and Competitiveness (MAT2017-86450-C4-1-R, RyC-2015-18626)
- Spanish National Research Council (201560E068)
This publication has 40 references indexed in Scilit:
- Gold nanoparticles as efficient antimicrobial agents for Escherichia coli and Salmonella typhiBMC Chemistry, 2013
- Size-Dependent Bacterial Growth Inhibition and Mechanism of Antibacterial Activity of Zinc Oxide NanoparticlesLangmuir, 2011
- Toxicity of ZnO Nanoparticles toEscherichia coli: Mechanism and the Influence of Medium ComponentsEnvironmental Science & Technology, 2011
- NDM-1 — A Cause for Worldwide ConcernNew England Journal of Medicine, 2010
- Antibiotic resistance and its cost: is it possible to reverse resistance?Nature Reviews Microbiology, 2010
- Understanding biophysicochemical interactions at the nano–bio interfaceNature Materials, 2009
- Enhanced bioactivity of ZnO nanoparticles—an antimicrobial studyScience and Technology of Advanced Materials, 2008
- Antibacterial activity of ZnO nanoparticle suspensions on a broad spectrum of microorganismsFEMS Microbiology Letters, 2008
- Nanosilver: A nanoproduct in medical applicationToxicology Letters, 2008
- Structure, X-ray photoelectron spectroscopy and photoluminescence properties of highly ordered ZnO microrodsOptical Materials, 2005